Diagnóstico y tratamiento de la deficiencia de vitamina D

Os cuelgo una revisión clínica publicada  BMJ sobre vitamina D.

Aviso: tostón para los que no nos dedicamos a esto

Diagnosis and management of vitamin D deficiency

BMJ 2010; 340 doi: http://dx.doi.org/10.1136/bmj.b5664 (Published 11 January 2010)

Cite this as: BMJ 2010;340:b566

Summary Points

  • Vitamin D insufficiency is common in the UK population

  • Vitamin D deficiency typically presents with bony deformity (rickets) or hypocalcaemia in infancy and childhood, and with musculoskeletal pain and weakness in adults

  • Many other health problems—including cardiovascular disease, type 2 diabetes, several cancers, and autoimmune conditions—have recently been associated with vitamin D insufficiency

  • Risk factors include skin pigmentation, use of sunscreen or concealing clothing, being elderly or institutionalised, obesity, malabsorption, renal and liver disease, and anticonvulsant use

  • Vitamin D status is most reliably determined by assay of serum 25-hydroxyvitamin D (25-OHD)

  • Rickets and osteomalacia should be treated with high strength calciferol (ergocalciferol or colecalciferol) for 8-12 weeks, followed by regular vitamin D supplements

Rickets in children and osteomalacia in adults are the classic manifestations of profound vitamin D deficiency. In recent years, however, non-musculoskeletal conditions—including cancer, metabolic syndrome, infectious and autoimmune disorders—have also been found to be associated with low vitamin D levels.1 The spectrum of these common disorders is of particular concern because observational studies have demonstrated that vitamin D insufficiency is widespread in many northern regions of the world, including industrialised countries.2 3 The increasing prevalence of disorders linked to vitamin D deficiency is reflected in the several hundred children with rickets treated each year in the UK.4 However, these children represent a small proportion of the individuals with a suboptimal vitamin D status in the UK population.1 3 5

A recent nationwide survey in the United Kingdom showed that more than 50% of the adult population have insufficient levels of vitamin D and that 16% have severe deficiency during winter and spring.5 The survey also demonstrated a gradient of prevalence across the UK, with highest rates in Scotland, northern England, and Northern Ireland.5 People with pigmented skin are at high risk, as are the elderly; obese individuals; those with malabsorption, short bowel, or renal or liver disease; and individuals taking anticonvulsants, rifampicin, or highly active antiretroviral drugs.

In this article we discuss the diagnosis and management of vitamin D insufficiency and deficiency in children and adults according to evidence from descriptive and observational studies, randomised trials, and meta-analyses.

What are the sources of vitamin D?

Vitamin D refers to the precursors of the active secosteroid hormone 1,25-dihydroxyvitamin D3 (1,25-OH2D3), also known as calcitriol. The major natural source of vitamin D is from skin photosynthesis following ultraviolet B solar irradiation (box 1).

Box 1 Sources of vitamin D

  • Ultraviolet B sunlight exposure

  • >90% of mankind’s vitamin D supply is derived from ultraviolet B light

  • Oily fish including trout, salmon, mackerel, herring, sardines, anchovies, pilchards, and fresh tuna

  • Amount will depend on preparation, with smoked herring containing approximately 4 μg (160 IU) per 100 g and raw herring 40 μg (1600 IU) per 100 g

  • Cod liver oil and other fish oils

  • Egg yolk

  • 0.5 μg (20 IU) per yolk)

  • Mushrooms

  • Small quantities

  • Supplemented breakfast cereals, mainly supermarket “own brands” in the UK

  • Typically between 2 μg and 8 μg (80-320 IU) per 100 g

  • Margarine and infant formula milk

  • Statutory supplementation in the UK

In a fair skinned person, 20 minutes to 30 minutes of sunlight exposure on the face and forearms at midday is estimated to generate the equivalent of around 2000 IU of vitamin D. Two or three such sunlight exposures a week are sufficient to achieve healthy vitamin D levels in summer in the UK. For individuals with pigmented skin and, to a lesser extent, the elderly, exposure time or frequency need to be increased twofold to 10-fold to get the same level of vitamin D synthesis as fair skinned young individuals.6 w1 Unfortunately, for six months of the year (October to April), all of Scandinavia, much of western Europe (including 90% of the UK), and 50% of the North American landmass lies above the latitude that permits exposure to the ultraviolet B wavelengths necessary for vitamin D synthesis,w2 leaving millions of people reliant on exogenous sources of vitamin D.

Given this periodic lack of photosynthesis at high latitudes, vitamin D is also a micronutrient. Only a relatively small number of foods contain substantial amounts of vitamin D, the most significant dietary sources being oily fish and cod liver oil.7 The farmed fish that is commonly consumed in the UK may have less vitamin D content than wild fish.w3 Egg yolk, liver, and wild mushrooms contain small quantities of vitamin D. The amount in most vegetable sources is negligible.

The recommended daily intake of vitamin D in the UK is 400 IU (10 μg) per day for an adult, 280 IU (7 μg) for children aged between 6 months and 3 years, and 340 IU (8.5 μg) per day for infants under 6 months.7 However, these recommendations only provide sufficient vitamin D to prevent osteomalacia and rickets,8 and such an intake alone, in the absence of skin synthesis, will not provide optimal status. Accordingly, several learned bodies have recently increased their recommendations for vitamin D intake.9 w4

Food supplementation policies differ considerably between countries. Milk is widely fortified, but in the UK only infant formula milk and margarine have statutory vitamin D supplementation (1-2.5 μg (40-100 IU) per 100 kCal and 8 μg (320 IU) per 100 g, respectively). Thus, the typical UK diet, and that of many other countries, is profoundly lacking in vitamin D. A low dietary vitamin D intake, combined with the lack of skin synthesis for half of the year, is reflected in the disturbingly high prevalence of vitamin D insufficiency across the UK.3 5

How can vitamin D deficiency and insufficiency be determined?

Vitamin D status is most reliably determined by assay of serum 25-hydroxyvitamin D (25-OHD). Individuals with symptomatic osteomalacia or rickets have serum 25-OHD concentrations of less than 25 nmol/l (10 μg/l), reflecting profound vitamin D deficiency (table 1). A much larger proportion of the UK population (about 50% in spring) have vitamin D insufficiency, with serum 25-OHD concentrations between 25 nmol/l and 50 nmol/l (10-20 μg/l).3 5

View this table:

Table 1

 Serum 25-hydroxyvitamin D concentrations, health, and disease

Several observational studies have shown that vitamin D insufficiency, although not enough to cause symptomatic bone and muscle disease, is associated with an increased risk of mortality10 11 12 13 and of several common diseases including cardiovascular disease,12 13 type 2 diabetes,14 bowel cancer, breast cancer,1516 multiple sclerosis,17 and type 1 diabetes18 (table 2). An expert consensus is developing that optimal vitamin D status, reflected by optimal calcium handling and best health, is when serum concentrations of 25-OHD are 75 nmol/l (30 μg/l) or more.8 19 Serum 25-OHD has a circulating half life of two to three weeks, but levels are regularly replenished from fat stores.
View this table:

Table 2

 Evidence for association of circulating 25-hydroxyvitamin D level or vitamin D supplementation with major health outcomes

Circulating active vitamin D (1,25-dihydroxyvitamin D3 or calcitriol) has a short half life and is closely linked to parathyroid hormone production. Serum levels of calcitriol do not reflect vitamin D status and should not be measured unless abnormalities of vitamin D metabolism are suspected.

Who is at risk of vitamin D insufficiency and deficiency?

At northern latitudes, the major risk factor for D insufficiency and deficiency at all ages is pigmented skin (box 2). This is also a key risk factor in sunnier climates such as Australia, where a large case series has demonstrated an increasing incidence of vitamin D deficiency in young people.20 This report and many European case series of children with vitamin D deficiency over the last 20 years have consisted primarily of immigrant children or first generation offspring of immigrant parents with dark skin. In a recent report from Denmark, however, half of very young patients with nutritional rickets were ethnic Europeans.21

Box 2 Risk factors for vitamin D insufficiency and deficiency

  • Pigmented skin (non-white ethnicity)

  • Lack of sunlight exposure or atmospheric pollution

  • Skin concealing garments or strict sunscreen use

  • Exclusively breast fed

  • Multiple, short interval pregnancies

  • Elderly, obese, or institutionalised

  • Vegetarian (or other non-fish eating) diet

  • Malabsorption, short bowel, or cholestatic liver disease

  • Use of anticonvulsants, rifampicin, cholestyramine, highly active antiretroviral treatment (HAART), or glucocorticoids

Sunscreen with a sun protection factor 15 or more blocks more than 99% of dermal vitamin D synthesis. Strict adherence to use of sunscreens when outdoors, or the use of a veil, headscarf, or other concealing clothing, places individuals with fair skin at similar risk of vitamin D deficiency to those with pigmented skin. Elderly and institutionalised individuals are at risk because of the relatively large amount of time such people spend indoors, as well as a reduced dermal capacity to generate vitamin D.

Numerous case series and some experimental studies highlight the fact that vitamin D deficiency may be present at birth, with neonatal and infant vitamin D status dependent upon maternal vitamin D status.w5 w6 Multiparity, short spacing between pregnancies, and non-white maternal skin are major risk factors for vitamin D deficiency.w7 22 Infants exclusively breast fed, particularly beyond six months of age, are at increased risk because the vitamin D content of breast milk will not meet their requirements.22 Delayed introduction of solid food, picky eating habits, and poor diet also raise the risk.

The Department of Health recommends daily supplementary vitamin drops containing 400 IU of calciferol for all infants and preschool children,23 and this view is endorsed by the European Society for Paediatric Endocrinology.24Supplementation is particularly important for infants in the north of the UK, those with darker skin pigmentation, and fussy eaters.23

Weaning foods frequently contain low quantities of calcium, and nutritional rickets (as a consequence of calcium and not vitamin D deficiency) has been reported in children with adequate levels of 25-OHD.w8 Such findings reinforce the importance of focusing on the calcium content of a child’s diet in addition to vitamin D status.w9

How do patients with vitamin D deficiency present?

Children

Severe vitamin D deficiency may cause hypocalcaemic seizures or tetany, particularly in the neonatal period and again during the phase of rapid growth in adolescence. From the age of 6 months, children with vitamin D deficiency commonly present with bony deformity (rickets). Bowing of the legs (genu varum) is typical, but knock knees (genu valgum) can also occur. Anterior bowing of the femur and internal rotation at the ankle are frequently found, along with swelling at the wrist, prominent costochondral joints, and a soft, deformable skull (craniotabes).25 Children with vitamin D deficiency may be irritable and reluctant to weight bear, and manifest impaired growth.21 22 Height is usually affected more profoundly than weight.21

An increased susceptibility to infections and respiratory symptoms in children with vitamin D deficiency may be a manifestation of “rachitic lung,” where respiratory function is compromised by a pliable rib cage and muscle weakness.w10 Severe vitamin D deficiency can result in cardiomyopathy and potentially fatal heart failure.w11

Adults

Pain and proximal muscle weakness dominate the clinical picture of vitamin D deficiency in adults. Rib, hip, pelvis, thigh, and foot pain are typical. More diffuse muscular aches and muscle weakness, including in the limbs and back, are also common and may be labelled as “fibromyalgia” or as a somatisation of depression.26 Low bone density on dual energy X ray absorptiometry scanning, or osteopenia on plain radiography, may also reflect osteomalacia, and these findings warrant assessment of vitamin D status.

What investigations are necessary?

Children

Vitamin D deficiency should be suspected in children with known risk factors who are unwell with pain, irritability, and poor growth or skeletal deformity, and in all children with a seizure disorder. Blood can be taken in primary care for measurement of levels of calcium, phosphate, alkaline phosphatase, and serum 25-OHD, which is the most robust marker for vitamin D status (table 1). Haemoglobin levels should also be measured because iron deficiency anaemia frequently coexists with rickets.w12Parathyroid hormone concentrations are typically elevated in neonates and young infants with vitamin D deficiency, but may be within the reference range.

If there is diagnostic uncertainty—because of atypical clinical manifestations, a lack of risk factors, atypical biochemistry, focal pain, or asymmetrical deformity—then radiographs should be arranged to confirm rickets. In addition, a small number of children have hereditary or renal rickets. These rarer diagnoses need to be considered in the absence of known risk factors, in the presence of atypical biochemistry (for example, persistent hypophosphataemia, normal alkaline phosphatase, or elevated creatinine), and in children who fail to reduce alkaline phosphatase levels or respond clinically following vitamin D treatment. Referral for specialist assessment is appropriate in these circumstances.

The clinician must be vigilant for a secondary cause of vitamin D deficiency in both children and adults, such as covert coeliac disease or cystic fibrosis causing malabsorption.

Adults

More than 80% of adults with osteomalacia have a high concentration of serum alkaline phosphatase. Hypocalcaemia and hypophosphataemia are less consistently present, depending on the severity and chronicity of the disease and the patient’s dietary calcium intake. Elevation of plasma parathyroid hormone—secondary hyperparathyroidism—is typical of osteomalacia but is not found in about 20% of adults with vitamin D insufficiency. It is good practice to image areas of focal pain in adults, particularly if they persist or worsen during treatment (suggesting bony metastases).27

How should rickets and osteomalacia be treated?

Children

Oral calciferol in the bioequivalent forms of either ergocalciferol (yeast derived vitamin D2) or colecalciferol (fish or lanolin derived vitamin D3) is the treatment of choice for children with rickets.9 25 27 The principal aim of therapy is to replenish vitamin D stores; patients are then continued on a lower maintenance dose. Large bolus doses are also equally effective. Tablet, capsule, or oily suspensions of calciferol are available (box 3).

Box 3 Preparations of calciferol available in the UK

Solutions and drops
  • Dalivit (LPC Pharmaceuticals Ltd, Luton, Bedfordshire)*

  • Colecalciferol 400 IU per 0.6 ml

  • Abidec (Chefaro UK, Huntingdon, Cambridgeshire)*

  • Colecalciferol 400 IU per 0.6 ml

  • Healthy Start vitamin drops*

  • Colecalciferol 300 IU per 5 drops

  • Ergocalciferol oily solution

  • 3000 IU/ml

Tablets and capsules†
  • Calcium and vitamin D (400 mg calcium and 400 IU ergocalciferol)

  • Colecalciferol 20 000 IU (Dekristol; MIBE, Brehna, Germany)

  • Ergocalciferol 10 000 IU or 50 000 IU (UCB Pharma, Slough, Berkshire)

Parenteral
  • Ergocalciferol 300 000 IU per ml

  • *Multivitamin preparations; not suitable for prolonged high dose therapy owing to the risk of vitamin A toxicity.

  • †Other ergocalciferol and colecalciferol preparations are available off prescription.

Children aged less than 1 year should be treated with 3000 IU of calciferol daily, increasing to 6000 IU daily after 1 year of age (box 4).22 24 Calcium supplementation (50 mg/kg a day) is advisable during the first weeks of therapy in the growing child.22 20 A maintenance dose of 400 IU calciferol daily is appropriate for a child of any age.22 A relatively rapid biochemical response is typically seen in children, with normalisation of alkaline phosphatase levels within three months. It is likely that the mother, siblings, and other family members of a child with rickets are also vitamin D deficient.9 At a minimum, a maintenance dose of calciferol is recommended for other family members.

Box 4 Treatment of vitamin D deficiency and insufficiency

Deficiency (25-OHD <25 nmol/l)
ADULT
  • 10 000 IU calciferol daily or 60 000 IU calciferol weekly for 8-12 weeks*

  • or

  • Calciferol 300 000 or 600 000 IU orally or by intramuscular injection once or twice

CHILD
  • Under 6 months: 3000 IU calciferol daily for 8-12 weeks

  • Over 6 months: 6000 IU calciferol daily for 8-12 weeks

  • or

  • Over 1 year: 300 000 IU calciferol, as a one off high dose therapy (Stoss regimen)†

Insufficiency (25-OHD 25-50 nmol/l) or maintenance therapy following deficiency
ADULT
  • 1000-2000 IU calciferol daily

  • or

  • 10 000 IU calciferol weekly

CHILD
  • Under 6 months: 200-400 IU calciferol daily‡

  • Over 6 months: 400-800 IU calciferol daily

  • *To convert IU to μg of calciferol, divide by 40.

  • †One off high dose treatments are effective, but should be followed by a maintenance therapy dose of calciferol.

  • ‡200 IU may be inadequate for breastfed babies with low vitamin D stores at birth.

Adults

Calciferol has a high therapeutic index. It has been estimated that a regular daily dose of 1000 IU raises serum 25-OHD by 25 nmol/l28; however, vitamin D toxicity occurs at 25-OHD values above 500 nmol/l.29 In adults, calciferol treatment, in a daily dose of 10 000 IU or a weekly dose of 60 000 IU, will lead to restoration of body stores of vitamin D over eight to 12 weeks. Thereafter, a maintenance dose of 1000-2000 IU calciferol daily or 10 000 IU weekly is adequate. Short acting, potent vitamin D analogues such as 1-α calcidol or calcitriol are ineffective in correcting vitamin D deficiency and may lead to hypercalcaemia. Clinicians should avoid giving combined calcium and vitamin D preparations in the long term because the calcium component is usually unnecessary, makes for unpalatability, and reduces concordance.

In adults with severe malabsorption, or those in whom concordance with oral therapy is suspect, an intramuscular dose of 300 000 IU calciferol monthly for three months followed by the same dose once or twice a year is an alternative treatment approach. Pathological lesions in the bone are characterised by undermineralisation and may take many months to heal. Levels of serum alkaline phosphatase and parathyroid hormone will start to decline during the first three months of treatment in adults, but may take a year to fall into the reference range. Given that few adults have truly reversible risk factors for vitamin D deficiency, the assumption should be that supplementation will be needed life long, or life long during winter months (dependent upon latitude and dress habits).

How should moderate vitamin D insufficiency be managed?

From a public health perspective, primary prevention of vitamin D deficiency in a country such as the UK is socially as well as medically justifiable.30 The key groups for healthcare professionals to target are infants, children, adolescents, and pregnant women, particularly those with dark skin. Many individuals of non-white ancestry living in the Midlands and north of the UK are at particularly high risk of vitamin D insufficiency (including doctors). Most elderly and institutionalised people in other areas of the UK are also at high risk. Fair skinned people who eat oily fish twice weekly or who get regular suberythematous sunlight exposure through outdoor work or leisure activity may have adequate vitamin D status; most other fair skinned people will be vitamin D insufficient, particularly in the winter and spring.

Given the clear and mounting evidence of the substantial disease burden associated with moderate vitamin D insufficiency (table 2), information about appropriate sunlight exposure, the use of vitamin D supplements, and eating oily fish should be made available to the whole population. In particular, health visitors and midwives can implement current Department of Health recommendations by distributing children’s vitamin drops, which should be universally available through Healthy Start, Sure Start, and similar government schemes. Furthermore, we believe that a more robust approach to statutory food supplementation with vitamin D (for example, in milk) is needed in the UK, as this measure has already been introduced successfully in many other countries at similar latitude.

Conclusions

Vitamin D deficiency and insufficiency are common in the UK. Health professionals have been slow to respond to this problem even though the issue has been highlighted in the literature for a number of years. Rickets and osteomalacia are entirely preventable diseases that are becoming increasingly common in the UK population, and vitamin D insufficiency now seems unequivocally linked to several other common and morbid conditions. Local initiatives have been implemented to address this issue, but the high number of patients presenting with symptomatic vitamin D insufficiency highlights the fact that we have some way to go. A change in UK public health policy is long overdue.

Sources and selection criteria

We searched the PubMed database for articles including the term vitamin D. We identified further references from the original articles and recent review articles. We only studied articles in the English language, and gave priority to systemic reviews, meta-analyses, and clinical guidelines published within the last 10 years.

Tips for the non-specialist

  • Suspicions regarding a suboptimal vitamin D status in someone at risk are likely to be correct

  • Treatment is not the same as supplementation: the recommended daily amount of 400 IU vitamin D will be insufficient to treat an adult with osteomalacia and will lead to very slow response in most children with rickets

  • If a child has vitamin D insufficiency or deficiency, assume the mother and other siblings are similarly affected and will need therapy as well

  • Compliance with long term vitamin D supplementation is often poor: one off, high dose oral or intramuscular therapy is an effective option if concordance is suspect

Unanswered questions

  • How much does vitamin D insufficiency contribute to north/south health inequality in the UK?

  • Would eradication of vitamin D insufficiency in the UK reduce cancer incidence and improve cancer outcomes?

  • Does poor vitamin D status cause obesity, or is it a consequence of obesity?

  • Are individuals genetically susceptible to vitamin D insufficiency or toxicity?

Ongoing research

More than 150 clinical trials of vitamin D are listed on ClinicalTrials.gov. Some key trials include:

  • The VITamin D and omegA-3 TriaL (VITAL)

  • A study of colecalciferol 2000 IU daily, fish oil, or placebo in 20 000 older individuals (>60 yrs), with cardiovascular disease and cancer incidence as outcomes.

  • Vitamin D and Calcium Homeostasis for Prevention of Type 2 Diabetes (CaDDM) (NCT00436475)

  • Treatment of vitamin D insufficiency: does vitamin D increase calcium absorption, bone mass and muscle mass and function in women past menopause who have mildly low vitamin D levels? (NCT00933244)

  • Evaluation of vitamin D requirements during pregnancy (NCT00292591)

  • Development of vitamin D as a therapy for breast cancer—phase II (NCT00656019)

  • Vitamin D supplement in preventing colon cancer in African Americans with colon polyps (NCT00870961)

  • Health benefits of vitamin D and calcium in women with PCOS (polycystic ovarian syndrome) (NCT00743574)

  • Vitamin D3 supplementation and the T cell compartment in multiple sclerosis (MS) (NCT00940719)

Additional educational resources

Resources for healthcare professionals

Notes

Cite this as: BMJ 2010;340:b5664

Footnotes

  • We are very grateful to G Rylance, W Ross, and R Quinton for helpful comments on the manuscript, and to P Chen for sharing supplementary data included in their meta-analysis.17

  • Contributors: SP and TC both wrote the original manuscript and subsequent revisions.

  • Funding: No funding was received.

  • Competing interests: All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare (1) No financial support for the submitted work from anyone other than their employer; (2) No financial relationships with commercial entities that might have an interest in the submitted work; (3) No spouses, partners, or children with relationships with commercial entities that might have an interest in the submitted work; (4) No non-financial interests that may be relevant to the submitted work.

  • Provenance and peer review: Commissioned; externally peer reviewed.

References

  1. Holick MF. Vitamin D: a D-lightful health perspective. Nutrition Rev2008;66:S182-S194.
  2. Ginde AA, Liu MC, Camargo CA. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med2009;169:626-32.
  3. Ford L, Graham V, Wall A, Berg J. Vitamin D concentrations in a UK inner-city multicultural outpatient population. Ann Clin Biochem2006;43:468-73.
  4. Pal BR, Shaw NJ. Rickets resurgence in the United Kingdom: improving antenatal management in Asians. J Pediatr2001;139:337-8.
  5. Hyppönen E, Power C. Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors. Am J Clin Nutr2007;85:860-8.
  6. Working group of the Australian and New Zealand Bone and Mineral Society, Endocrine Society of Australia and Osteoporosis Australia. Vitamin D and adult bone health in Australia and New Zealand: a position statement. Med J Austral2005;182:281-5.
  7. Department of Health. Nutrition and bone health: report of the subgroup on bone health, working group on the nutritional status of the population. Stationery Office, 1998.
  8. Vieth R, Bischoff-Ferrari H, Boucher BJ, Dawson-Hughes B, Garland CF, Heaney RP, et al. The urgent need to recommend an intake of vitamin D that is effective. Am J Clin Nutr2007;85:649-50.
  9. Wagner CL, Greer FR for the American Academy of Pediatrics Section on Breastfeeding and the American Academy of Pediatrics Committee on Nutrition. Prevention of rickets and vitamin D deficiency in infants, children, and adolescents. Pediatrics2008;122:1142-52.
  10. Autier P, Gandini S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med2007;167:1730-7.
  11. Melamed ML, Michos ED, Post W, Astor B. 25-hydroxyvitamin D levels and risk of mortality in the general population. Arch Intern Med2008;168:1629-37.
  12. Ginde A, Scragg R, Schwartz RS, Camargo CA. Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older US adults. J Am Geriatr Soc2009;57:1595-603.
  13. Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, Wellnitz B, et al.Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med2008;168:1340-9.
  14. Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes: a systematic review and meta-analysis. J Clin Endocrinol Metab2007;92:2017-29.
  15. Yin L, Grandi N, Raum E, Haug U, Arndt V, Brenner H. Meta-analysis: longitudinal studies of serum vitamin D and colorectal cancer risk. Aliment Pharmacol Ther2009;30:113-25.
  16. Chen P, Hu P, Xie D, Qin Y, Wang F, Wang H. Meta-analysis of vitamin D, calcium and the prevention of breast cancer. Breast Cancer Res Treat 2009; published online 23 Oct.
  17. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA2006;296:2832-8.
  18. Zipitis CS, Akobeng AK. Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis. Arch Dis Child2008;93:512-7.
  19. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr2006;84:18-28.
  20. Robinson PD, Högler W, Craig ME, Verge CF, Walker JL, Piper AC, et al. The re-emerging burden of rickets: a decade of experience from Sydney. Arch Dis Child2006;91:564-8.
  21. Beck-Nielsen SS, Jensen TK, Gram J, Brixen K, Brock-Jacobsen B. Nutritional rickets in Denmark: a retrospective review of children’s medical records from 1985 to 2005. Eur J Pediatr2009;168:941-9.
  22. Misra M, Pacaud D, Petryk A, Collett-Solberg PF, Kappy M for the Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society. Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics2008;122:398-417.
  23. Department of Health. Feeding your child. In: Birth to Five: 2007 edition. www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_074924.
  24. Hochberg Z, Bereket A, Davenport M, Delemarre-Van de Waal HA, De Schepper J, Levine MA, et al for the European Society for Paediatric Endocrinology (ESPE) Bone Club. Consensus development for the supplementation of vitamin D in childhood and adolescence. Horm Res2002;58:39-51.
  25. Wharton B, Bishop N. Rickets. Lancet2003;362:1389-400.
  26. Sievenpiper JL, McIntyre LA, Verrill M, Quinton R, Pearce SHS. Unrecognised severe vitamin D deficiency. BMJ2008;336:1371-4.
  27. Anon. Primary vitamin D deficiency in adults. DTB2006;44:25-9.
  28. Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr2003;77:204-10.
  29. Kimball S, Vieth R. Self-prescribed high-dose vitamin D3: effects on biochemical parameters in two men. Ann Clin Biochem2008;45:106-110.
  30. Lucas RM, McMichael AJ, Armstrong BK, Smith WT. Estimating the global disease burden due to ultraviolet radiation exposure. Int J Epidemiol2008;37:654-67.
Follow

Get every new post on this blog delivered to your Inbox.

Join other followers: